Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal logo Université Clermont Auvergne & associés

Human Nutrition Unit

Zone de texte éditable et éditée et rééditée

To prevent and predict

     
From the identification of muscle loss biomarkers and protein malnutrition to interventional strategies to preserve organ function



    Identify biomarkers of muscle atrophy in humans
Muscle loss is an aggravating factor of several pathologies. However, no predictive tool exists for its early detection while it is almost impossible to revert muscle atrophy when it is established. 
Click to read more

 


Our goal is to identify biomarkers witnessing the development of muscle atrophy independently of the pathology. As a first step, we have identified 238 markers in skeletal muscles that are specifically over or under expressed during lung cancer or chronic kidney disease.

Our current studies focus on the identification of blood markers highly linked to the development of muscle atrophy. Our final goal is the development of a tool dedicated to routine detection of a catabolic situation in hospitals and/or to the follow-up of anabolic treatments.

To provide an integrative view of muscle aging in human, we combine proteomics, transcriptomics, immunohistology and molecular imaging to study sub-cohorts of elderly subjects without/with age-related pathologies. Using these methodologies, we identified potential biomarkers of muscle aging, and describe age/pathologies-related alterations in muscle fiber metabolism, lipid droplets, apoptosis, capillarization, satellite cells and fibrosis.

Investigators
Julien Aniort, Daniel Béchet, Agnès Claustre, Cécile Coudy-Gandilhon, Anne-Elisabeth Heng, Cécile Polge, Daniel Taillandier

 




    Identification of predictive epigenetic marks of predisposition to the development of obesity
Context
Metabolic diseases (obesity, diabetes, etc.) are rising to dramatic proportions worldwide, making them a major public health issue. These pathologies are largely due to environmental causes, among which disorders associated with our lifestyle play an important role (diet, sedentary lifestyle, stress, etc.).
Click to read more
However, all individuals are not equal when faced with environmental stresses and an individual's predisposition to the development of obesity results from interactions between one' s intrinsic predisposition and the environment. While genetic factors seem to play only a limited role, numerous epidemiological studies report that nutrition during the perinatal period is an important determinant of the individual's health status throughout life. These observations have led to the concept of Developmental Origins of Health and Disease (DOHaD). Thus, it has been shown (mainly by Barker et al.) that a maternal nutritional stress can result in specific adaptations in the fetus leading to an impairment of its physiology and metabolism and an increased predisposition to metabolic diseases in adulthood.
Identification of early predictive markers of obesity predisposition
Experimental models in rodents have shown that the imprints of the maternal environment can be epigenetic. The term epigenetics describes stable alterations in gene expression that do not involve any change in the DNA sequence. Epigenome development takes place during development, is strongly influenced by the environment, and is maintained through mitosis. The main epigenetic processes involved in the regulation of gene expression are the DNA methylation , post-translational modifications of histones and deregulated expression of small non-coding RNAs (in particular microRNAs: miRNAs).
We hypothesize that epigenetic imprints, occurring very early in development, can be considered as early predictive markers of susceptibility to the development of metabolic diseases.
Thus, we set up experimental nutritional models in mice, resulting in opposite obesity predisposition phenotypes (sensitive vs. resistant to the development of obesity). From these models, our project consists in identifying predictive epigenetic markers (DNA methylation and miRNA) specifically correlated to the observed metabolic phenotypes and having a predictive value, i.e. detectable before the appearance of clinical signs.
On the long term, our objective is to evaluate in humans all the previously identified epigenetic marks so that we can draw up a predictive test of predisposition to obesity to propose, before any clinical signs and any alteration of physiological indicators, a preventive treatment.

References

Investigators
Pierre Fafournoux, Céline Jousse, Laurent Parry